Sinequan 50mg Capsules

Manufacturer PFIZER Active Ingredient Doxepin Capsules(DOKS e pin) Pronunciation DOKS-e-pin
WARNING: Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in children. Talk with the doctor. @ COMMON USES: It is used to treat depression.It is used to treat anxiety.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antidepressant, Anxiolytic, Sedative, Antipruritic
đŸ§Ŧ
Pharmacologic Class
Tricyclic Antidepressant (TCA)
🤰
Pregnancy Category
Category C
✅
FDA Approved
Mar 1969
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Doxepin is a medication that belongs to a group of drugs called tricyclic antidepressants. It works by affecting certain chemicals in the brain to help improve mood, reduce anxiety, and can also be used to help with sleep or relieve itching. It's important to take it exactly as prescribed by your doctor.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, it's essential to follow your doctor's instructions carefully. Read all the information provided with your medication and follow the instructions closely. If you're taking this medication once a day, take it at bedtime. Continue taking your medication as directed by your doctor or healthcare provider, even if you're feeling well.

Storing and Disposing of Your Medication

To maintain the quality and safety of your medication, store it at room temperature, protected from light, and in a dry place. Avoid storing it in a bathroom. Keep all medications in a secure location, out of the reach of children and pets. When disposing of unused or expired medications, do not flush them down the toilet or pour them down the drain unless instructed to do so. Instead, check with your pharmacist for guidance on the best disposal method. You may also want to explore local drug take-back programs in your area.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
💡

Lifestyle & Tips

  • Avoid alcohol and other sedating medications, as doxepin can increase drowsiness.
  • Be cautious when driving or operating machinery until you know how this medication affects you.
  • To minimize dizziness or lightheadedness, especially when starting treatment, get up slowly from a sitting or lying position.
  • Maintain good oral hygiene to help with dry mouth (e.g., sugar-free gum/candies, frequent sips of water).
  • Increase fiber and fluid intake to help prevent constipation.
  • Report any new or worsening symptoms, especially changes in mood, behavior, or thoughts of self-harm, to your doctor immediately.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Varies by indication. For depression/anxiety: 75-150 mg/day, typically divided or as a single bedtime dose. For insomnia: 3-6 mg once daily at bedtime. For pruritus: 10-30 mg once daily at bedtime.
Dose Range: 3 - 300 mg

Condition-Specific Dosing:

depression_anxiety: Initial: 25-75 mg/day, gradually increase to 75-150 mg/day. Max: 300 mg/day for severe cases.
insomnia: 3-6 mg once daily at bedtime (Silenor brand).
pruritus: 10-30 mg once daily at bedtime (oral solution or capsules for off-label use).
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for depression/anxiety. Use for pruritus (off-label): 0.5-1 mg/kg/day at bedtime, max 25 mg/day.
Adolescent: Not established for depression/anxiety. Black Box Warning regarding suicidality in pediatric and young adult patients.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment recommended, monitor for adverse effects.
Moderate: No specific adjustment recommended, monitor for adverse effects.
Severe: Use with caution, consider lower doses and monitor for adverse effects due to potential accumulation of parent drug and active metabolites.
Dialysis: Not well studied. Doxepin is highly protein-bound, so dialysis is unlikely to be effective in removing it. Use with caution.

Hepatic Impairment:

Mild: Use with caution, consider lower doses and monitor for adverse effects.
Moderate: Significant dose reduction (e.g., 50-75% reduction) may be necessary. Monitor plasma levels if available.
Severe: Contraindicated or not recommended due to extensive hepatic metabolism and risk of accumulation.
Confidence: Medium

Pharmacology

đŸ”Ŧ

Mechanism of Action

Doxepin is a tricyclic antidepressant (TCA) that primarily inhibits the reuptake of norepinephrine (NE) and serotonin (5-HT) at presynaptic neuronal membranes, thereby increasing their concentrations in the synaptic cleft. It also possesses potent antihistaminic (H1), anticholinergic, and alpha-1 adrenergic blocking properties, which contribute to its sedative, anxiolytic, and adverse effects.
📊

Pharmacokinetics

Absorption:

Bioavailability: Variable (20-45%) due to extensive first-pass metabolism.
Tmax: 2-4 hours (parent drug), 6-8 hours (active metabolite, desmethyldoxepin).
FoodEffect: Food may delay absorption but does not significantly affect the extent of absorption.

Distribution:

Vd: 9-33 L/kg (large volume of distribution, indicating extensive tissue binding).
ProteinBinding: >90% (primarily to albumin).
CnssPenetration: Yes (readily crosses the blood-brain barrier).

Elimination:

HalfLife: 10-25 hours (doxepin), 28-51 hours (desmethyldoxepin).
Clearance: Not readily available, but extensive hepatic metabolism.
ExcretionRoute: Primarily renal (as metabolites).
Unchanged: <3% (excreted unchanged in urine).
âąī¸

Pharmacodynamics

OnsetOfAction: Sedative/hypnotic effects: 30-60 minutes. Antidepressant/anxiolytic effects: 2-4 weeks.
PeakEffect: Sedative/hypnotic effects: 1-3 hours. Antidepressant/anxiolytic effects: 4-6 weeks.
DurationOfAction: Sedative/hypnotic effects: 6-8 hours (low dose). Antidepressant/anxiolytic effects: 24 hours (due to long half-life).

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of Sinequan or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high or low blood pressure, including:
+ Severe headache or dizziness
+ Passing out
+ Changes in eyesight
Fast heartbeat
Difficulty urinating
Feeling extremely nervous or excitable
Fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling very tired or weak
Yellowing of the skin or eyes (jaundice)
Ringing in the ears (tinnitus)
Changes in sex drive
Enlarged breasts or nipple discharge
Swelling of the testicles

Important Warning for Asthma Patients

If you have asthma, use this medication with caution. Some people with asthma have experienced worsening symptoms while taking this medication. If your asthma symptoms worsen, contact your doctor immediately.

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. Contact your doctor or seek medical help if you experience any of the following side effects or if they persist or bother you:

Dizziness, drowsiness, tiredness, or weakness
Constipation, diarrhea, stomach pain, upset stomach, vomiting, or decreased appetite
Dry mouth
Changes in taste
Mouth irritation or mouth sores
Weight gain
Excessive sweating
Flushing
Hair loss
* Headache

Reporting Side Effects

This list is not exhaustive, and you may experience other side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Thoughts of suicide or self-harm
  • New or worsening depression or anxiety
  • Agitation, restlessness, panic attacks
  • Difficulty sleeping (insomnia)
  • Irritability, hostility, aggressiveness
  • Impulsivity
  • Extreme increase in activity and talking (mania)
  • Severe dizziness or fainting
  • Fast or irregular heartbeat
  • Difficulty urinating
  • Severe constipation
  • Blurred vision or eye pain
  • Seizures
  • Yellowing of skin or eyes (jaundice)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced.
Certain health conditions, such as:
+ Urinary retention (trouble passing urine)
+ Glaucoma
Current or recent use of specific medications, including:
+ Linezolid or methylene blue
+ Monoamine oxidase inhibitors (MAOIs) for depression or Parkinson's disease, such as isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, within the last 14 days (as this may increase the risk of very high blood pressure)
Use of other medications that can cause drowsiness, as there are many drugs that can have this effect. If you are unsure, consult your doctor or pharmacist.
* Breastfeeding, as you should not breastfeed while taking this medication.

This list is not exhaustive, and it is crucial to inform your doctor and pharmacist about all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, as well as any health problems you may have. This will help ensure your safety while taking this medication. Never start, stop, or change the dose of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

When you first start taking this drug, be cautious when driving or performing tasks that require your full attention, as it may affect your alertness. You may not experience the full effects of this medication for several weeks.

To minimize the risk of side effects, do not abruptly stop taking this medication without consulting your doctor. If you need to discontinue use, your doctor will provide guidance on how to gradually taper off the medication.

While taking this drug, it is recommended that you avoid consuming alcohol. Additionally, consult your doctor before using marijuana, cannabis, or any prescription or over-the-counter medications that may cause drowsiness or impair your reactions.

Some individuals may be at a higher risk of developing eye problems while taking this medication. Your doctor may recommend an eye exam to assess your risk. If you experience eye pain, changes in vision, or swelling and redness in or around the eye, contact your doctor immediately.

This medication may increase your sensitivity to the sun, making you more prone to sunburn. Take necessary precautions when spending time outdoors, and inform your doctor if you experience excessive sunburn.

If you have diabetes, it is crucial to closely monitor your blood sugar levels while taking this medication. Be aware of the signs of high or low blood sugar, which may include fruity breath odor, dizziness, rapid breathing, rapid heartbeat, confusion, drowsiness, weakness, flushing, headache, unusual thirst or hunger, frequent urination, shaking, or sweating. Report any of these symptoms to your doctor.

Older adults (65 years and older) should use this medication with caution, as they may be more susceptible to side effects.

Certain medications, including this one, may affect fertility. If you have concerns about your ability to have children, discuss this with your doctor.

If you are pregnant or planning to become pregnant, consult your doctor to weigh the benefits and risks of taking this medication. Using this drug during the third trimester of pregnancy may pose health risks to the newborn, so it is essential to discuss this with your doctor.
🆘

Overdose Information

Overdose Symptoms:

  • Severe drowsiness or coma
  • Confusion, disorientation, hallucinations
  • Dilated pupils
  • Fast, irregular, or pounding heartbeat (tachycardia, arrhythmias)
  • Low blood pressure (hypotension)
  • Respiratory depression (slow, shallow breathing)
  • Seizures
  • Muscle rigidity or uncontrolled movements
  • Fever
  • Urinary retention
  • Dry mouth and skin

What to Do:

Seek immediate emergency medical attention. Call 911 or your local poison control center (1-800-222-1222 in the US). Do not induce vomiting. Treatment is supportive and symptomatic, often involving gastric lavage, activated charcoal, and monitoring of cardiac function (ECG) and vital signs. Physostigmine may be used for severe anticholinergic toxicity, but with caution due to potential for cardiac effects.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) - risk of hyperpyretic crisis, severe convulsions, and death.
  • Cisapride - risk of QT prolongation and arrhythmias.
  • Pimozide - risk of QT prolongation and arrhythmias.
🔴

Major Interactions

  • CNS Depressants (e.g., alcohol, benzodiazepines, opioids, sedatives, hypnotics) - additive CNS depression.
  • Anticholinergics (e.g., atropine, benztropine, diphenhydramine) - additive anticholinergic effects (e.g., severe constipation, urinary retention, blurred vision, delirium).
  • Sympathomimetics (e.g., epinephrine, norepinephrine, phenylephrine) - potentiation of cardiovascular effects (hypertension, arrhythmias).
  • CYP2D6 Inhibitors (e.g., fluoxetine, paroxetine, quinidine) - increased doxepin plasma concentrations.
  • Thyroid hormones - increased risk of cardiac arrhythmias and toxicity.
  • Antihypertensives (e.g., guanethidine, clonidine) - may antagonize antihypertensive effects.
🟡

Moderate Interactions

  • Cimetidine - increased doxepin plasma concentrations.
  • Warfarin - potential for altered anticoagulant effect (monitor INR).
  • Anticonvulsants (e.g., carbamazepine, phenytoin) - altered doxepin levels or increased risk of seizures.
  • Other serotonergic drugs (e.g., SSRIs, SNRIs, triptans) - risk of serotonin syndrome (though less pronounced than with MAOIs).
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

ECG (Electrocardiogram)

Rationale: To assess for pre-existing cardiac conduction abnormalities or QT prolongation, especially in patients with cardiac disease or elderly.

Timing: Prior to initiation of therapy.

Blood Pressure (BP) and Heart Rate (HR)

Rationale: To establish baseline and monitor for orthostatic hypotension or tachycardia.

Timing: Prior to initiation of therapy.

Mental Status Examination (MSE) / Suicidality Assessment

Rationale: To establish baseline mood, thought content, and assess for suicidal ideation, especially in young adults and adolescents.

Timing: Prior to initiation of therapy.

Liver Function Tests (LFTs)

Rationale: To assess hepatic function, as doxepin is extensively metabolized by the liver.

Timing: Prior to initiation of therapy, especially in patients with suspected hepatic impairment.

📊

Routine Monitoring

Mental Status Examination (MSE) / Suicidality Assessment

Frequency: Weekly during initial titration, then periodically (e.g., monthly for first few months, then quarterly) or as clinically indicated.

Target: Improvement in target symptoms without emergence or worsening of suicidal ideation.

Action Threshold: Any new or worsening suicidal ideation, agitation, or unusual behavioral changes require immediate re-evaluation and intervention.

Blood Pressure (BP) and Heart Rate (HR)

Frequency: During dose titration, then periodically (e.g., monthly) or as clinically indicated.

Target: Within patient's normal range, without significant orthostatic drops.

Action Threshold: Symptomatic orthostatic hypotension, persistent tachycardia, or significant hypertension.

Anticholinergic Side Effects (e.g., dry mouth, constipation, urinary retention, blurred vision)

Frequency: Regularly, especially during dose titration.

Target: Minimal or manageable side effects.

Action Threshold: Severe or intolerable side effects, especially urinary retention or acute angle-closure glaucoma symptoms.

Sedation/Drowsiness

Frequency: Regularly, especially during initial therapy.

Target: Manageable level of sedation, ideally at bedtime.

Action Threshold: Excessive daytime sedation impairing daily activities or safety.

Therapeutic Drug Monitoring (TDM) - Doxepin and Desmethyldoxepin levels

Frequency: Not routinely recommended, but may be considered in cases of suspected non-adherence, toxicity, or lack of response.

Target: Doxepin + Desmethyldoxepin: 100-250 ng/mL (for depression/anxiety).

Action Threshold: Levels outside therapeutic range, especially high levels associated with toxicity.

đŸ‘ī¸

Symptom Monitoring

  • Worsening depression
  • Emergence of suicidal thoughts or behavior
  • Unusual changes in behavior (e.g., agitation, irritability, hostility, impulsivity, mania/hypomania)
  • Anxiety
  • Panic attacks
  • Insomnia
  • Restlessness
  • Severe dry mouth
  • Constipation
  • Urinary retention
  • Blurred vision
  • Dizziness or lightheadedness (especially upon standing)
  • Palpitations or irregular heartbeat
  • Confusion or delirium (especially in elderly)
  • Seizures

Special Patient Groups

🤰

Pregnancy

Doxepin is Pregnancy Category C. Use during pregnancy should only be considered if the potential benefit justifies the potential risk to the fetus. Neonates exposed to TCAs in the third trimester have developed withdrawal symptoms (e.g., respiratory distress, feeding difficulties, tremor, hypertonia, hypotonia, seizures).

Trimester-Specific Risks:

First Trimester: Limited human data, but animal studies show adverse effects. Potential for increased risk of congenital malformations cannot be ruled out.
Second Trimester: Limited data. Risk of withdrawal symptoms in neonates if exposure continues into third trimester.
Third Trimester: Risk of neonatal withdrawal syndrome (e.g., respiratory distress, feeding difficulties, irritability, tremor, hypotonia, seizures) and persistent pulmonary hypertension of the newborn (PPHN).
🤱

Lactation

Doxepin and its active metabolite are excreted into breast milk. The American Academy of Pediatrics considers doxepin to be a drug for which the effect on the nursing infant is unknown but may be of concern. Potential for sedation, poor feeding, and weight gain in the infant. Use with caution, or consider alternative agents, especially in neonates or preterm infants.

Infant Risk: Moderate (L3) - Monitor infant for sedation, irritability, poor feeding, and weight gain.
đŸ‘ļ

Pediatric Use

Generally not recommended for depression/anxiety in children and adolescents due to the Black Box Warning regarding increased risk of suicidality. Safety and efficacy for these indications have not been established. May be used off-label for pruritus in children, but with careful dose titration and monitoring.

👴

Geriatric Use

Elderly patients are more sensitive to the anticholinergic, sedative, and orthostatic hypotensive effects of doxepin. Start with lower doses and titrate slowly. Increased risk of falls, confusion, and urinary retention. Avoid in patients with dementia due to anticholinergic burden. Monitor closely for adverse effects and consider lower therapeutic ranges.

Clinical Information

💎

Clinical Pearls

  • Doxepin is a potent H1 antagonist, making it highly sedating. This property is leveraged for its use in insomnia at very low doses (3-6 mg).
  • Due to its anticholinergic properties, doxepin should be used with extreme caution or avoided in patients with benign prostatic hyperplasia (BPH), narrow-angle glaucoma, or severe constipation.
  • Orthostatic hypotension is a common side effect, especially at higher doses or in elderly patients. Advise patients to rise slowly.
  • The full antidepressant effect may take 2-4 weeks to develop, but sedative effects are immediate.
  • Withdrawal symptoms (e.g., nausea, headache, malaise, flu-like symptoms, sleep disturbance, irritability) can occur if discontinued abruptly, especially after prolonged use. Taper dose gradually.
  • Overdose can be life-threatening due to cardiac arrhythmias and CNS depression. Always prescribe the smallest effective quantity, especially for patients at risk of suicide.
🔄

Alternative Therapies

  • Other Tricyclic Antidepressants (TCAs): Amitriptyline, Nortriptyline, Imipramine
  • Selective Serotonin Reuptake Inhibitors (SSRIs): Fluoxetine, Sertraline, Escitalopram
  • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): Venlafaxine, Duloxetine
  • Other Antidepressants: Mirtazapine, Bupropion
  • For Insomnia: Zolpidem, Eszopiclone, Trazodone, Suvorexant, Lemborexant
  • For Pruritus: Antihistamines (e.g., Hydroxyzine, Diphenhydramine), topical corticosteroids
💰

Cost & Coverage

Average Cost: $20 - $100 per 30 capsules (50mg generic)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (generic), Tier 3 or higher (brand)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others or take someone else's medication. This medication is accompanied by a Medication Guide, which is a valuable resource for patients. Please read this guide carefully and review it again whenever you receive a refill of this medication. If you have any questions or concerns about this medication, we encourage you to discuss them with your doctor, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide detailed information, including the substance taken, the amount, and the time it occurred.